Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jul;90(1):22-34.
doi: 10.1002/ana.26051. Epub 2021 Mar 6.

Common X-Chromosome Variants Are Associated with Parkinson Disease Risk

Yann Le Guen #  1 , Valerio Napolioni #  2 , Michael E Belloy  1 , Eric Yu  3   4 , Lynne Krohn  3   4 , Jennifer A Ruskey  4   5 , Ziv Gan-Or  3   4   5 , Gabriel Kennedy  1 , Sarah J Eger  1 , Michael D Greicius  1
Affiliations
Meta-Analysis

Common X-Chromosome Variants Are Associated with Parkinson Disease Risk

Yann Le Guen et al. Ann Neurol. 2021 Jul.

Abstract

Objective: The objective of this study was to identify genetic variants on the X-chromosome associated with Parkinson disease (PD) risk.

Methods: We performed an X-chromosome-wide association study (XWAS) of PD risk by meta-analyzing results from sex-stratified analyses. To avoid spurious associations, we designed a specific harmonization pipeline for the X-chromosome and focused on a European ancestry sample. We included 11,142 cases, 280,164 controls, and 5,379 proxy cases, based on parental history of PD. Additionally, we tested the association of significant variants with (1) PD risk in an independent replication with 1,561 cases and 2,465 controls and (2) putamen volume in 33,360 individuals from the UK Biobank.

Results: In the discovery meta-analysis, we identified rs7066890 (odds ratio [OR] = 1.10, 95% confidence interval [CI] = 1.06-1.14, p = 2.2 × 10-9 ), intron of GPM6B, and rs28602900 (OR = 1.10, 95% CI = 1.07-1.14, p = 1.6 × 10-8 ) in a high gene density region including RPL10, ATP6A1, FAM50A, and PLXNA3. The rs28602900 association with PD was replicated (OR = 1.16, 95% CI = 1.03-1.30, p = 0.016) and shown to colocalize with a significant expression quantitative locus (eQTL) regulating RPL10 expression in the putamen and other brain tissues in the Genotype-Tissue Expression Project. Additionally, the rs28602900 locus was found to be associated with reduced brain putamen volume. No results reached genome-wide significance in the sex-stratified analyses.

Interpretation: We report the first XWAS of PD and identify 2 genome-wide significant loci. The rs28602900 association was replicated in an independent PD dataset and showed concordant effects in its association with putamen volume. Critically, rs26802900 is a significant eQTL of RPL10. These results support a role for ribosomal proteins in PD pathogenesis and show that the X-chromosome contributes to PD genetic risk. ANN NEUROL 2021;90:22-34.

PubMed Disclaimer

Conflict of interest statement

Potential Conflicts of Interest

Nothing to report.

Figures

FIGURE 1:
FIGURE 1:
X-chromosome wide analyses reveal 2 genome-wide significant loci in the combined sex meta-analysis. X-chromosome–wide sex-stratified discovery analyses in males (A) and in females (B) and combined sex meta-analysis (C) are shown. The most significantly regulated gene in brain tissues (RPL10) or the nearest gene (GPM6B) is annotated on top of the lead single nucleotide polymorphism at each locus. The horizontal line indicates the genome-wide significance threshold (p < 5 × 10−8).
FIGURE 2:
FIGURE 2:
LocusZoom plots of the genome-wide significant loci in the combined sex meta-analysis.
FIGURE 3:
FIGURE 3:
Forest plots of the genome-wide significant loci in the combined sex meta-analysis, emphasizing the consistent direction of effect of the respective lead variants across datasets. ACT = Adult Change in Thought; AMP PD = Accelerating Medicines Partnership–Parkinson’s Disease; APDGC = Autopsy-Confirmed PD GWAS Consortium; CI = confidence interval; EBI = European Bioinformatics Institute; IPDGC = International PD Genomics Consortium; NGRC = NeuroGenetics Research Consortium; NINDS = National Institute of Neurological Disorders and Stroke; PDCGC = Parkinson’s Disease Cognitive Genetics Consortium; psex-het = p value from the sex-heterogeneity test; UKB = UK Biobank.
FIGURE 4:
FIGURE 4:
Colocalization analyses between association with Parkinson disease (PD) risk and association with gene expression in brain tissues. (A) The locus, on Xq28, associated with PD risk colocalized with the RPL10 expression quantitative locus (eQTL) in the putamen (and in the 10 other Genotype-Tissue Expression Project brain tissues with false discovery rate [FDR]-significant RPL10 eQTLs; data not shown). (B) The locus, on Xq28, associated with PD risk did not colocalize with the PLXNA3 eQTL in the putamen (or in other brain tissues with FDR-significant PLXNA3 eQTLs). Rather, the eQTL signal is driven by a nearby eQTL locus in low linkage disequilibrium with the PD risk locus. PP4 = posterior probability of colocalization; XWAS = X-chromosome–wide association study.
See this image and copyright information in PMC

Comment in

Similar articles

  • Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study.
    Foo JN, Chew EGY, Chung SJ, Peng R, Blauwendraat C, Nalls MA, Mok KY, Satake W, Toda T, Chao Y, Tan LCS, Tandiono M, Lian MM, Ng EY, Prakash KM, Au WL, Meah WY, Mok SQ, Annuar AA, Chan AYY, Chen L, Chen Y, Jeon BS, Jiang L, Lim JL, Lin JJ, Liu C, Mao C, Mok V, Pei Z, Shang HF, Shi CH, Song K, Tan AH, Wu YR, Xu YM, Xu R, Yan Y, Yang J, Zhang B, Koh WP, Lim SY, Khor CC, Liu J, Tan EK. Foo JN, et al. JAMA Neurol. 2020 Jun 1;77(6):746-754. doi: 10.1001/jamaneurol.2020.0428. JAMA Neurol. 2020. PMID: 32310270 Free PMC article.
  • Characterizing the Genetic Architecture of Parkinson's Disease in Latinos.
    Loesch DP, Horimoto ARVR, Heilbron K, Sarihan EI, Inca-Martinez M, Mason E, Cornejo-Olivas M, Torres L, Mazzetti P, Cosentino C, Sarapura-Castro E, Rivera-Valdivia A, Medina AC, Dieguez E, Raggio V, Lescano A, Tumas V, Borges V, Ferraz HB, Rieder CR, Schumacher-Schuh A, Santos-Lobato BL, Velez-Pardo C, Jimenez-Del-Rio M, Lopera F, Moreno S, Chana-Cuevas P, Fernandez W, Arboleda G, Arboleda H, Arboleda-Bustos CE, Yearout D, Zabetian CP; 23andMe Research Team; Cannon P, Thornton TA, O'Connor TD, Mata IF; Latin American Research Consortium on the Genetics of Parkinson's Disease (LARGE-PD). Loesch DP, et al. Ann Neurol. 2021 Sep;90(3):353-365. doi: 10.1002/ana.26153. Epub 2021 Jul 22. Ann Neurol. 2021. PMID: 34227697 Free PMC article.
  • X-Chromosome Association Study in Latin American Cohorts Identifies New Loci in Parkinson's Disease.
    Leal TP, Rao SC, French-Kwawu JN, Gouveia MH, Borda V, Bandres-Ciga S, Inca-Martinez M, Mason EA, Horimoto ARVR, Loesch DP, Sarihan EI, Cornejo-Olivas MR, Torres LE, Mazzetti-Soler PE, Cosentino C, Sarapura-Castro EH, Rivera-Valdivia A, Medina AC, Dieguez EM, Raggio VE, Lescano A, Tumas V, Borges V, Ferraz HB, Rieder CR, Schumacher Schuh A, Santos-Lobato BL, Velez-Pardo C, Jimenez-Del-Rio M, Lopera F, Moreno S, Chana-Cuevas P, Fernandez W, Arboleda G, Arboleda H, Arboleda Bustos CE, Yearout D, Barbosa MT, Cardoso FEC, Caramelli P, Cunningham MCQ, Maia DP, Lima-Costa MF, Tarazona-Santos E, Zabetian CP; International Parkinson Disease Genomics Consortium (IPDGC); Thornton TA, O'Connor TD, Mata IF; Latin American Research Consortium on the Genetics of Parkinson's Disease (LARGE-PD). Leal TP, et al. Mov Disord. 2023 Sep;38(9):1625-1635. doi: 10.1002/mds.29508. Epub 2023 Jul 20. Mov Disord. 2023. PMID: 37469269
  • Identification of a novel Parkinson's disease locus via stratified genome-wide association study.
    Hill-Burns EM, Wissemann WT, Hamza TH, Factor SA, Zabetian CP, Payami H. Hill-Burns EM, et al. BMC Genomics. 2014 Feb 10;15:118. doi: 10.1186/1471-2164-15-118. BMC Genomics. 2014. PMID: 24511991 Free PMC article.
  • Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
    Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T; PD GWAS Consortium. Pankratz N, et al. Ann Neurol. 2012 Mar;71(3):370-84. doi: 10.1002/ana.22687. Ann Neurol. 2012. PMID: 22451204 Free PMC article.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wirdefeldt K, Gatz M, Reynolds CA, et al. Heritability of Parkinson disease in Swedish twins: a longitudinal study. Neurobiol Aging 2011;32:1923.e1–1923.e8. - PMC - PubMed
    1. Nalls MA, Blauwendraat C, Vallerga CL, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 2019;18:1091–1102. - PMC - PubMed
    1. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015–1022. - PubMed
    1. Wooten GF, Currie LJ, Bovbjerg VE, et al. Are men at greater risk for Parkinson’s disease than women? J Neurol Neurosurg Psychiatry 2004;75:637–639. - PMC - PubMed
    1. Taylor KSM, Cook JA, Counsell CE. Heterogeneity in male to female risk for Parkinson’s disease. J Neurol Neurosurg Psychiatry 2007;78: 905–906. - PMC - PubMed

Publication types